Many calves develop pneumonia days before showing symptoms. Lung ultrasounds are helping veterinarians detect the hidden ...

Underwriters were given a 30-day option to purchase up to 1.74 million additional shares. ・Trevi is currently developing Haduvio, its treatment for chronic cough in patients with idiopathic pulmonary ...

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

Patients with SSc who have gastric dysmotility present with a more severe disease phenotype and are associated with an increased risk for adverse outcomes.

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn ...

A subgroup of patients with SSc who exhibit a severe GI phenotype were associated with longer disease duration, ACA positivity, PAH, and worse quality of life.

A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

Adults aged over 65 with chronic respiratory disease should be offered the respiratory syncytial virus (RSV) vaccine, JCVI ...

Clinical trial designed to evaluate ROC-101 in combination with standard of care therapies including sotatercept NATICK, Mass. /PRNewswire/ -- AllRock Bio, Inc., a ...